2025-09-04 |
13G/A
|
HGTY / Hagerty, Inc.
|
|
0 |
5,306,865 |
|
|
|
2025-08-14 |
13G/A
|
HGTY / Hagerty, Inc.
|
|
5,002,477 |
0 |
|
|
|
2025-08-14 |
13G/A
|
ARQT / Arcutis Biotherapeutics, Inc.
|
|
6,706,475 |
5,006,472 |
|
|
|
2025-08-14 |
13G
|
ELVN / Enliven Therapeutics, Inc.
|
|
2,389,668 |
2,536,881 |
|
|
|
2025-05-15 |
13G
|
NPCE / NeuroPace, Inc.
|
|
|
2,972,003 |
|
|
|
2025-05-15 |
13G/A
|
ARQT / Arcutis Biotherapeutics, Inc.
|
|
6,297,688 |
6,706,475 |
|
|
|
2025-02-14 |
13G/A
|
VTEX / VTEX
|
|
10,538,673 |
5,232,020 |
|
|
|
2025-02-14 |
13G/A
|
ELVN / Enliven Therapeutics, Inc.
|
|
2,687,797 |
2,389,668 |
|
|
|
2024-11-13 |
13G/A
|
CLDX / Celldex Therapeutics, Inc.
|
|
3,135,871 |
2,711,163 |
|
|
|
2024-11-13 |
13G/A
|
BRKR / Bruker Corporation
|
|
|
317,928 |
|
|
|
2024-11-13 |
13G/A
|
AVDL / Avadel Pharmaceuticals plc
|
|
6,751,782 |
4,803,899 |
|
|
|
2024-11-13 |
13G
|
VTEX / VTEX
|
|
|
10,538,673 |
|
|
|
2024-11-13 |
13G
|
HGTY / Hagerty, Inc.
|
|
|
5,002,477 |
|
|
|
2024-11-13 |
13G
|
ELVN / Enliven Therapeutics, Inc.
|
|
|
2,687,797 |
|
|
|
2024-02-13 |
13G
|
CLDX / Celldex Therapeutics, Inc.
|
|
|
3,135,871 |
|
|
|
2024-02-13 |
13G/A
|
SYRE / Spyre Therapeutics, Inc.
|
|
|
500,000 |
|
|
|
2024-02-13 |
13G
|
AVDL / Avadel Pharmaceuticals plc
|
|
2,794,673 |
6,751,782 |
|
|
|
2024-02-13 |
13G/A
|
RVNC / Revance Therapeutics, Inc.
|
|
4,848,633 |
3,169,239 |
|
|
|
2024-02-13 |
13G/A
|
ARQT / Arcutis Biotherapeutics, Inc.
|
|
7,117,944 |
6,297,688 |
|
|
|
2024-02-13 |
13G/A
|
NSTGQ / NS Wind Down Co., Inc.
|
|
3,778,731 |
3,975,000 |
|
|
|
2023-11-16 |
13G
|
ARQT / Arcutis Biotherapeutics, Inc.
|
|
|
7,117,944 |
|
|
|
2023-07-28 |
13G
|
AGLE / Aeglea BioTherapeutics Inc
|
|
|
3,936,198 |
|
|
|
2023-07-13 |
13G/A
|
NSTGQ / NS Wind Down Co., Inc.
|
|
3,778,731 |
3,778,731 |
|
|
|
2023-02-14 |
13G
|
RVNC / Revance Therapeutics, Inc.
|
|
|
4,848,633 |
|
|
|
2023-02-14 |
13G/A
|
SMMT / Summit Therapeutics Inc.
|
|
6,295,713 |
0 |
|
|
|
2023-02-14 |
13G/A
|
INFIQ / Infinity Pharmaceuticals, Inc.
|
|
5,000,000 |
2,071,242 |
|
|
|
2023-02-14 |
13G
|
NSTGQ / NS Wind Down Co., Inc.
|
|
|
3,778,731 |
|
|
|
2023-02-14 |
13G/A
|
QTNT / Quotient Ltd
|
|
9,251,653 |
0 |
|
|
|
2022-02-14 |
13G/A
|
BLU / Bellus Health Inc
|
|
3,500,000 |
2,500,000 |
|
|
|
2022-02-14 |
13G/A
|
SUMM / SUMMIT THERAPEUTICS PLC
|
|
5,800,000 |
6,295,713 |
|
|
|
2022-02-14 |
13G/A
|
/ Oxford Immunotec Global PLC
|
|
2,568,385 |
0 |
|
|
|
2022-02-14 |
13G/A
|
QTNT / Quotient Ltd
|
|
9,251,653 |
9,251,653 |
|
|
|
2022-02-14 |
13G
|
INFI / Infinity Pharmaceuticals Inc.
|
|
|
5,000,000 |
|
|
|
2022-02-14 |
13G/A
|
AVDL / Avadel Pharmaceuticals plc
|
|
6,027,705 |
2,794,673 |
|
|
|
2021-02-16 |
13G/A
|
BLU / Bellus Health Inc
|
|
|
3,500,000 |
|
|
|
2021-02-16 |
13G/A
|
/ Oxford Immunotec Global PLC
|
|
|
2,568,385 |
|
|
|
2021-02-16 |
13G/A
|
QTNT / Quotient Ltd
|
|
|
9,251,653 |
|
|
|
2021-02-16 |
13G
|
SUMM / SUMMIT THERAPEUTICS PLC
|
|
|
5,800,000 |
|
|
|
2021-02-16 |
13G
|
AVDL / Avadel Pharmaceuticals plc
|
|
|
6,027,705 |
|
|
|